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he hedgehog signalling pathway is critical to normal
ammalian gastrointestinal development. Through ep-
thelial-mesenchymal interactions, hedgehog signalling
nsures appropriate axial patterning of the embryonic
ut. Congenital abnormalities, including malrotations,
norectal malformations, and tracheoesophageal fistula
re associated with germ-line mutations/deletion of
enes encoding hedgehog signalling components in
an and present in genetically engineered animal mod-
ls. In adults, there is evidence that the pathway plays a
ole in maintaining stem cell populations in the stomach
nd directing epithelial cell differentiation in the intes-
ine. Recent data implicate hedgehog signalling in the
ormation and maintenance of a number of malignan-
ies, including those of the upper gastrointestinal (GI)
ract and pancreas, in which abrogation of the pathway
ffers a novel therapeutic approach in animal models.
ost recently, evidence in vitro indicates that there is a
ecapitulation of embryonic hedgehog signalling in
cute epithelial injury and chronic inflammation, a find-
ng with key implications for inflammatory disorders of
he intestine, such as inflammatory bowel diseases. This
athway may provide an important link between chronic
nflammation and cancer. We summarize the available
vidence demonstrating that this developmental path-
ay has continuing roles in adult homeostasis and is
ysregulated in malignancy and inflammation of the
astrointestinal tract.
t is becoming increasingly clear that signalling path-
ways important in prenatal development continue to
ave vital roles in adult life by directing differentiation,
etermining cell fate, maintaining stem cell niches, and
oordinating appropriate cellular responses to injury.
hese pathways influence many disease processes; in
ome situations, the normal critical balance of signalling
omponents is upset by inherited variants, whereas in
thers, ligand-driven up-regulation of signalling is a
ufficient driving force. The explosion of research intohese signalling pathways has revealed a multitude of
ovel therapeutic targets.
This review focuses on the hedgehog (Hh) signalling
athway and highlights how current insights into its role
n GI development have greatly increased our under-
tanding of adult health and disease. This pathway is
esponsible for several relatively common congenital
alformations such as tracheoesophageal fistula and ano-
ectal malformations. Hh signalling is strongly impli-
ated in maintaining stem cell niches in the stomach and
irecting enterocyte differentiation in the colon. Further-
ore, it plays critical roles both in the formation and in
he maintenance of GI malignancies, including pancre-
tic adenocarcinomas, cholangiocarcinoma, and colorec-
al cancer. Based on the increasing knowledge of how Hh
nteracts with the immune system, on its involvement in
arious non-GI inflammatory disorders, and on recently
ublished data,1 we hypothesize links between dysregu-
ation of this pathway and inflammatory disorders of the
I tract, in particular the inflammatory bowel diseases
nd associated malignancies.
Hh Signalling
The Hh signalling pathway was originally de-
cribed in the development of Drosophila melanogaster as a
egment polarity gene required for embryonic pattern-
ng.2 The genes involved in Drosophila are Hedgehog
Hh), Patched (Ptc), Smoothened (Smo), Hedgehog-interacting
rotein (HIP1), Costal-2 (Cos-2), Fused (Fu), Suppressor of
used (Su(Fu)), and Cubitus interruptus (Ci). The pathway
omponents demonstrate high interspecies conservation.3
Abbreviations used in this paper: Dhh, Desert hedgehog; EA/TEF,
sophageal atresia/tracheo-esophageal fistula; Hh, hedgehog; HIP,
edgehog-interacting protein; Ihh, Indian hedgehog; N-Hhp, processed
edgehog; Ptc, patched; Smo, smoothened; Shh, Sonic hedgehog.
















































November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1697here are 3 vertebrate homologues of Hh: Sonic hedgehog
Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh).
hese demonstrate different, but frequently overlapping,
xpression patterns. They have remarkably similar bio-
ogical properties, albeit with differing potency
ShhIhhDhh) noted in some, but not all, experimen-
al assays.4 Increasing evidence implicates accessory mol-
cules in mediating Hh activity,5–7 and there may be a
ole for these in modulating this potency. Most research
as centred on Shh. The 2 homologues for patched,
atched-1 (Ptc-1) and patched-2 (Ptc-2), both bind verte-
rate Hh with similar affinity. Ptc-1 is found in target
ells and up-regulated by Hh signalling.8 Ptc-2, although
ittle studied, is coexpressed with Hh and does not
epend on it for transcription.9,10 The 3 homologues for
i, Gli-1, Gli-2, and Gli-3, are responsible for many of
he refined complexities and intricacies observed in
ammalian Hh signalling.
Hh is synthesised as a 45-kilodalton precursor protein
igure 1. Hh signalling in mammalian cells. In the absence of Hh pr
ffect on Smo, a 7-pass transmembrane protein with homology to G-
vailability of the full Gli product.116 This occurs by a combination of m
urthermore, when Ptc is unoccupied by Hh, it is suggested that caspa
hat transduces an apoptotic signal via Gli-3. In the presence of Hh l
li product is now stabilized and transferred to the nucleus. This proce
omplex and also by interaction of Gli with a phosphorylated Su (F
ranscriptional targets, including Ptc and another Hh-binding protein,
he pathway.hat undergoes autoproteolysis.11–13 The active N-termi- fal signalling domain (N-Hh) is released once the cata-
ytic C-terminal portion has been removed and a choles-
erol molecule has been added (N-Hhp).14 With the
ddition of cholesterol, a modification to N-Hhp that is
nique among signalling molecules, N-Hhp is rendered
ydrophobic and thus able to bind to the cell membrane
t which it mediates local signals. In an independent
tep, the N-terminus can be further modified by palmi-
oylation, increasing hydrophobicity.15 Furthermore, N-
hp, once released from the cell via the transmembrane
rotein Dispatched,16 functions to provide a long-range,
aracrine signal to target cells.17 At the present time, the
echanisms involved in short-range and long-range sig-
alling remain contentious and under investigation. The
ransduction of the Hh signal has many interesting and
nique facets (Figure 1) that share some similarities with
nt signalling.18–20
As with most cell signalling pathways, regulatory
echanisms exist for Hh signalling. Hh activity induces
(A), the 12-transmembrane domain receptor Ptc exerts an inhibitory
in–coupled receptors. Smo, in complex with Cos-2, prevents nuclear
bule binding of the complex and proteolysis to a truncated Gli (GliTR).
casp-3) cleavage of its intra-cellular portion exposes a receptor region
-binding (B), the inhibitory action of Ptc on Smo is released. The full
likely mediated in part by conformational change in the Cos-2/Gli/Fu
nce in the nucleus, the full Gli product binds to and up-regulates



































































































1698 LEES ET AL GASTROENTEROLOGY Vol. 129, No. 5hus simultaneously initiating signalling while restrict-
ng the range of movement by sequestering Hh protein.
nother cell-surface protein that binds to and sequesters
h, HIP1,21,22 is also up-regulated by pathway activa-
ion, thus serving to down-regulate Hh activity. The
henotype of HIP knockout (HIP/) mice is consistent
ith increased Hh signalling.23 Megalin, a low-density
ipoprotein (LDL) receptor-related protein, is also active
n the cell surface and controls the endocytic uptake of
he Hh protein by acting as a direct binding partner in
itro, although little is known of its function in vivo.24,25
he regulation of Hh signalling at different levels indi-
ates that tight control is crucial to its proper function,
nalogous to regulation of other key signalling pathways,
uch as nuclear factor-B (NF-B), whose activation
nduces inhibitory molecules (IB and others).26
Hh Signalling in Development
Hh Signalling Is Critical in the Embryonic
Development of the GI System
The gut develops from a primitive endodermal
ube that gives rise to the pharynx, esophagus, stomach,
mall intestine, and colon. Endodermal buds grow into
esenchyme closely associated with the tube and form
he liver and pancreas. The key molecular pathways
nvolved are the Hh, bone morphogenetic protein
BMP), Notch, and Wnt/-catenin signalling pathways;
he Hox and Sox transcription factors; and the Eph
eceptor/ephrin ligand signalling system.27 Patterned
ene expression within the endoderm and surrounding
esoderm regulates the morphogenesis, differentiation,
nd boundaries of these organ primordia.28 The cross talk
enerated between endoderm and mesoderm is critical to
his process and later establishes radial patterning within
he developing digestive tract. Hh signals are a vital
omponent of this cross talk and thus essential to the
ormal patterning of the GI track along anterior-poste-
ior (A-P), dorsal-ventral (D-V), and radial axes.29 In the
nimal models studied, high levels of the Hh receptor
tc-1 in the mesenchyme allow for processing of the
ignals generated endodermally.30–34 Paracrine signal-
ing in the late gestational (E18.5), murine small intes-
ine has been elegantly demonstrated after careful sepa-
ation of these components.35 Shh and Ihh are present in
pithelial cells, with Ptc and Gli1-3 mRNA detected
lmost exclusively in the mesenchymal compartment.
h signals can, however, also act cell autonomously as
hey do in developing and adult pancreatic islets in
hich Ihh and Ptc-1 colocalize.36,37 Of great relevance,
anipulation/interruption of Hh components in animal
odels bears a close resemblance to many human con- menital malformations arising from abnormalities in fore-
nd hindgut development.
Developmental patterning by Hh in Drosophila is
argely dependent on concentration gradients.38 In the
ammalian ventral neural tube, the morphogenic gradi-
nts of Shh setup in the notochord and floor plate deter-
ine the differentiation of progenitors into several dif-
erent cell types (reviewed in McMahon et al, 200339). In
he developing gut, the overlap in expression of 2 Hh
omologues, Shh and Ihh, may serve to generate greater
ariation in concentration gradients. Additionally, the
ifferent phenotypes of the knockout mice (Shh/ and
hh/) suggest that the 2 homologues have different
unctions during intestinal development.
Hh proteins are highly expressed in the murine em-
ryonic gut and decrease after birth.34 Shh and Ihh are
xpressed in mouse gut endoderm in overlapping pat-
erns. From day 8.5 of gestation (E8.5), the proteins are
resent in 2 ventrolateral strips in gut endoderm.40 This
s noted first in the caudal hindgut, followed by foregut
ocket and then hindgut. Shh is down-regulated in 2
ritical areas: in the prospective pancreatic endoderm to
llow normal pancreatic development and along the
mall intestine, possibly to allow normal intestinal epi-
helial differentiation.41 By E18.5, there is expression of
hh and Ihh in the glandular stomach, small intestine,
nd colon. Shh is mostly restricted to colonic crypts at
his time.
Shh, Ihh, and Gli Knockout Mice
Shh/ and Ihh/ mice die peri- or immediately
ostnatally.31 Both mutant embryos (examined at E18.5)
how significant GI defects, both common (smaller,
vertly malrotated GI tracts) and distinct (Table 1).
here are no data reporting any such defects in Dhh/
ice (males are viable, but sterile because of defective
permatogenesis42).
The Shh/ embryo displays a hyperplastic stomach
pithelium with some intestinal transformation of the
landular epithelium. Overgrown villi in the duodenum
re seen to cause an occlusion similar to duodenal stenosis
n humans. On dissection, the colon terminates in a blind
ilatation leading to imperforate anus.31 Furthermore,
li-2/ and Gli-3/ mice exhibit, respectively, im-
erforate anus with rectourethral fistula and anal steno-
is.43 Mice with a truncated Gli-3 (Gli-3699/699), re-
embling the aberrant transcription factor in Pallister-
all syndrome, display imperforate anus, reduced size of
mall intestinal villi, dilated intestine, and thin-walled
olons.44 Gli-1//Gli-2/ double knockouts have a
ersistent cloaca, whereas the mixed homo-heterozygous



















































November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1699ose-dependent effect.43 Hh signalling is involved in the
evelopment of a normal hindgut, and, although prob-
bly important to the pathogenesis of human anorectal
alformations, this has yet to be studied in detail.
In both Hh knockouts, there is decreased thickness
f the circular smooth muscle layer along the small
ntestine (34% reduction for Ihh/ and 21% for
hh/ when compared with wild type).31 Both also
how abnormalities of the enteric nervous system
ENS). Shh/ mice have neurons that differentiate
bnormally under the epithelium and migrate into the
illi. The healthy epithelium is known to inhibit
roliferation of enteric neurons, an effect that is lost
hen Shh signalling is blocked with the general Hh
athway-inhibitor cyclopamine (Figure 2).45 Grafting
hh-expressing cells into the mesenchyme limits neu-
al proliferation in the vicinity. Furthermore, Shh
able 1. Phenotypes of the Various Hedgehog Component Kn
Genotype
(References) Lethality














hh//Ihh/ (31) Die: E8.0
pfI/Pdx1-Shh (59) Viable Pancreas
intestin
tc-1/ (36,123) Die: E9–10.5 Pancreas
tc-1/ (36) Viable Pancreas




illin-Hhip (35) Viable Small inte
ectopic
li-1/ (124) Viable No obviou




li-2/; Gli-3/ (43,51) Viable Foregut a
li-2/; Gli-3/ Perinatal Foregut: E
li-3/, Gli-2/ (43,51) Hindgut:
li-2/; Gli-3/ (43,51) Die: E10.5–E13.5 Foregut: E
hepatic
Hindgut:romotes proliferation of neural crest cells while in- pibiting differentiation and modulating their respon-
iveness to glial cell line-derived neurotrophic factor
GDNF).46 Taken together, these data strongly impli-
ate Shh signalling in proper radial patterning of the
NS.
Ihh/ mice (and to a lesser extent Gli-3699/699
ice44) macroscopically exhibit marked dilatation of the
mall intestine and parts of the colon, corresponding to a
icroscopic absence of neurones.31 Some neurones are
resent in a normal pattern in patches of nondilated
olon. This colonic phenotype is observed with a pen-
trance of approximately 50%. The inference is that
eural crest cells can migrate into the gut and differen-
iate, but, in the absence of Ihh locally, they fail to
urvive or proliferate. Interestingly, this phenotype re-
embles Hirschsprung disease (HSCR) in humans. The 1
tudy to assess a genetic link failed to associate Ihh
out and Transgenic Mice
Phenotype
GI defects
size 30% of wild type; small, malrotated GI tract
F with severe lung hypoplasia.
rplastic gastric epithelium, increased number of glucagon-positive
: Decreased smooth muscle thickness; overgrowth of duodenal villi
eased size and endocrine cell number; annular pancreas
rforate anus
l differentiation of neurons under epithelium, with migration into
size 67% of wild type; small, malrotated GI tract
ular pancreas
roscopically dilated segments resemble Hirschprung’s
pic absence of neurons, corresponding to dilated segments of SI
upted morphogenesis; pancreatic mesoderm develops into
esenchyme
1, glucagon absent from pancreas at E9.5
es have impaired glucose tolerance
aired morphogenesis, islet formation, and endocrine cell
(enhanced effect in HIP/; Ptc/ that die before E13); small
leen
ed ratio of epithelial-mesenchymal thickness in posterior stomach
: Flattened hyperproliferative epithelium; mislocalized ISEMFs;
rypt structures
fects
lastic esophagus, with no development of smooth muscle and
forate anus with rectourethral fistula
stenosis.
indgut: No obvious defects
F
tent cloaca, less severe than double knockout
erm does not develop into esophagus, trachea, and lungs. Small
pancreatic buds















































































































1700 LEES ET AL GASTROENTEROLOGY Vol. 129, No. 5red.47 Gene-gene interactions between Ihh and the ma-
or HSCR genes may play a role.
Ihh is normally expressed in the intervilli region of the
mall intestine, the presumed stem cell compart-
ent.31,48 In the knockout animals, there is decreased
ize of the villi and a 54% reduction in cell proliferation
n the stem cell compartment. In the colon, these animals
lso lose the normal monolayer of epithelial cells with
rypt organization.49 This is replaced by multilayered
pithelial cells lacking crypts. These data implicate Ihh
n the regulation of stem cell proliferation and possibly
pithelial cell migration in the intestine.
The Shh and Ihh double knockout embryo arrests
igure 2. Methods of agonizing/antagonizing the Hh signalling path-
ay. Shh ligand can be prevented from binding to its receptor, Ptc, by
n anti-Shh monoclonal antibody 5E1.117 Several specific Smo inhib-
tors have been identified. Cyclopamine is a natural alkaloid derivate
solated from Veratum californicum, a plant of the lily family long
nown to be teratogenic to grazing pregnant ewes.118–121 Although
mpractical for human therapeutics because of difficulties of large-
cale production, blocking Hh signalling with cyclopamine does ap-
ear safe in treated mice.85,88 Pka agonists such as Forskolin can
ecrease pathway activity as they maintain the Gli family of transcrip-
ion factors in an inactive state. Alternatively blocking Gli RNA with
ntisense oligonucleotides has been shown to abrogate successfully
he Hh pathway activity in Xenopus.122 Curis Inc. has developed a
mall molecule Hh agonist (in partnership with Wyeth) and an antag-
nist (with Genentech) that have been tested in preclinical models
nd are now being evaluated in phase I clinical trials (http://
ww.curis.com).evelopment at early somite stages (E8.0). Utilizing the man-Hh inhibitor HIP under control of the mouse villin
romoter, Madison et al have generated a viable murine
odel to study the effects of abrogating all Hh signals in
he postnatal small intestine.35 The epithelium was
oted to be flattened, with significant interference of
illus formation and epithelial remodelling. Changes in
he mesenchyme (expansion of smooth muscle progeni-
ors and mislocalization of intestinal subepithelial myo-
broblasts [ISEMFs]) were found, in turn, to impact
urther on the epithelium with increased proliferation
nd enhanced -catenin/Tcf4 activity. In this manner,
he Hh pathway patterns the intestinal crypt-villus axis
ia a paracrine signal.
A further role for Hh signalling in the development
nd/or function of the murine postnatal intestine has
een suggested by Wang et al.34 In view of the lethality
f Shh/ and Ihh/ knockout mice above, these authors
tudied wild-type animals and blocked Hh signalling at
ate stages of pregnancy and immediately postnatally
ith the anti-Hh monoclonal antibody 5E1, which
locks Shh, Ihh, and Dhh. All pups died by 3 weeks,
aving displayed a runting and wasting phenotype post-
atally. It is of some interest that this corresponded with
he development of significant diarrhea. The small intes-
ines of these animals showed significant histopatholog-
cal abnormalities, notably disorganized villi projecting
nto the lumen, and hyperplastic crypts with a 73%
ncrease in proliferation compared with control animals.
urthermore, a prominent vesicular vacuolation was
oted in enterocytes, predominantly affecting ileum and
ecum. This defect became apparent only on postnatal
ay 2, having been absent 1 day previously even in
nimals treated with 5E1 from E12.5. It was also noted
o be an intestinal-specific phenomenon with no such
acuolation identified in other cell types, including hepa-
ocytes. Further characterization showed that these vacu-
les represent an intracellular accumulation of neutral
ipid (Oil Red O positive, PAS negative). The possible
nvolvement of Hh signalling postnatally in lipid absorp-
ion and secretion is also suggested by the numerous
icroscopic fat droplets in the stool of treated mice and
y decreases in serum apolipoprotein A-IV, total choles-
erol, and high-density lipoprotein cholesterol in these
nimals.
This is further supported by a recent study in adults,
emonstrating that monoclonal antibody-mediated inac-
ivation of Hh signalling in mice fed a high-fat diet
rotects against weight gain.50 Similarly treated leptin-
eficient mice (ob-ob) that ordinarily gain weight on a
ow-fat diet showed decreased weight gain compared
ith controls. Although total lipid absorption was nor-



























































































November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1701lowed, and there was increased fecal, free-fatty-acid
xcretion in the mAb-treated animals. Indeed, the he-
atic steatosis noted in the high-fat control group was
bolished with abrogation of Hh signalling. However,
hese data need to be interpreted with caution because
etailed studies of cyclopamine-treated animals demon-
trate increased Wnt/-catenin activity and colonic can-
ers49 (discussed in detail later). This could account for at
east a proportion of the weight loss demonstrated here.
Shh, Foregut Development, and Esophageal
Fistula/Tracheoesophageal Fistula
The development of esophageal fistula/tracheo-
sophageal fistula (EA/TEF) in Shh/ mice suggests a
ole for Hh signalling in the pathogenesis of this condi-
ion and in normal foregut development.30,31 Further-
ore, the human Gli genes are implicated in congenital
oregut malformations by the significant abnormalities
oted in the Gli-2 and Gli-3 knockout mice (Table 1).51
n normal murine development, foregut expression of
hh is particularly high when the trachea and esophagus
plit.52,53 At E10.5, the normal undivided foregut has a
entrally placed prospective trachea that is positive for
hh.54 By E11.5, this pattern is reversed with the sepa-
ated trachea now negative for Shh.30,54 However, anal-
sis of the adriamycin-induced rat model of EA/TEF
hows that, when the trachea is still undivided (at E11.5
n the rat, a slightly different developmental time point
o the mouse), there is a diffuse Shh staining pattern that
acks any dorsal-ventral gradient.54 The rat fistula tract
hows much lower Gli-2 levels than the adjacent esoph-
gus.55 Furthermore, culture of fistula tract with exoge-
ous Shh induces branching, a known Shh effect on the
eveloping lung.55 Examination of one resected human
stula tract in a newborn showed Shh in the proximal
sophageal pouch but not in the distal fistula tract.56
Combined, these data show that the fistula tract is of
espiratory, not esophageal, origin. Shh is vital to the
ormal development of the esophagus and trachea and
eavily involved in the pathogenesis of EA/TEF and
ACTERL (vertebral, anal, cardiac, tracheoesophageal
stula, radial, renal, and limb abnormalities) association
hat the adriamycin model mimics. In humans, both
oregut and hindgut anomalies are seen in some patients
ith holoprosencephaly (where mutant Shh causes cyclo-
ia). Because EA/TEF in humans do not appear to be
aused by genetic defects, an environmental association
n the early embryo that manipulates Hh signalling is
ore probable than a Hh mutation. What the relevant
rigger is remains unclear, although it has been shown to
e unrelated to maternal cocaine use as had been hypoth-
sized.57 hPancreatic Development
In contrast to the positive role played by Shh in
any tissues and organs, Shh inhibits pancreas morpho-
enesis and cell differentiation.58 Loss of Shh in prospec-
ive pancreatic endoderm is a critical step in normal
ancreatic development.41 Indeed, ectopic expression of
hh leads to disrupted expression of pancreatic markers
nd pancreatic morphogenesis.59 Cyclopamine treatment
f developing chicks allows ectopic budding of pancre-
tic structures and expression of pancreatic markers in
he stomach and duodenum.60 The Hh knockout mice
ave increased pancreatic mass and subsequently an an-
ular pancreas that mirrors the rare human congenital
alformation.31,36,61 Shh appears to inhibit pancreatic
evelopment and growth by its local expression in the
eveloping stomach and duodenum. Decreased local Hh
ignals allow ectopic branching of ventral pancreatic
issue that causes an annulus around the duodenum. Hh
nockout embryos also demonstrate relatively increased
ancreatic -cell and -cell numbers, Shh/ more than
hh/.36 Furthermore, Shh/ mice have increased gas-
ric glucagon-positive cells, indicating that Hh blocks
ndocrine cell differentiation in the pancreas and the
tomach.36 The pathway inhibitors HIP and Ptc-1 are
lso required for normal pancreatic development as dem-
nstrated in knockout mice (HIP/ and HIP/; Ptc/)
n which pancreatic growth and endodermal cell differ-
ntiation are impaired.23
Hh Signalling in Adult Health
Patterns of Expression in the Adult GI Tract
The main published survey of the Hh signalling
athway in the GI system in adult humans and rodents
as carried out by Van den Brink et al (Table 2).62 These
uthors demonstrated Shh mRNA to be abundantly ex-
ressed in the gastric fundus, in small quantities in the
rypts of the small intestine, and in a few colonic crypts
ut not in the esophagus or gastric antrum.1,62 When the
uthors used commercially available goat polyclonal anti-
hh antibody, they did not find any positive staining for
hh protein anywhere apart from in the gastric fundus.62
Subsequently, work from 3 separate teams has now
hown that Shh protein is present in the human co-
on.1,63,64 Oniscu et al in Edinburgh found protein in the
ytoplasm at the top of normal colonic crypts.64 This
ocalization was confirmed by the presence of Shh mRNA
n laser microdissected crypts. Similar protein findings
re reported by Dimmler et al, who show Shh expression
n the distal colon only.63 Most recently, Nielson et al
ave reported the presence of Shh mRNA by in situ



















































































1702 LEES ET AL GASTROENTEROLOGY Vol. 129, No. 5mall intestinal and colonic crypts, predominantly in the
ases but with some focal surface epithelial expression.1
The discrepancy in protein data likely reflects varying
rotein detection sensitivities in differing immunohisto-
hemistry protocols because different laboratories used
he same antibody. It may also reflect differences in
olonic sampling if the differential expression of Shh
cross the colon suggested by Dimmler et al is borne out
n larger data sets. This finding warrants further inves-
igation in light of newly published data demonstrating
ifferential expression of many different genes in the
ight and left colon.65 Alternatively, it is possible that
hh mRNA synthesis occurs at the crypt base, with
ranslation into protein happening as cells differentiate as
hey migrate toward the lumen.
Van den Brink et al have subsequently shown expres-
ion of Ihh mRNA and protein in the human colon
ocalizing to surface absorptive enterocytes.49 These same
ells were negative for Shh mRNA by in situ hybridiza-
ion.62 Little is known of Ihh expression in the rest of the
uminal digestive tract, but it is present in the pancreas
see below), in which Shh is absent, and in the liver.66
Further data are required to assess whether the 2 Hh
omologues occupy distinct niches within the colon or
hether they overlap and perform different biologic
unctions. Given the important function of Shh expres-
ion gradients during development, it seems likely that
radients of differential Shh/Ihh expression persist
ithin the adult digestive tract. These may function to
aintain structural and functional boundaries and/or
aintain stem cell populations. Blocking Hh signalling
ith cyclopamine is smoothened (Smo) specific, and the
nti-Shh monoclonal antibody 5E1 (Figure 2) also blocks
hh. Neither agent will therefore help distinguish be-
ween Shh and Ihh function. There are no published data
xamining Dhh expression in the adult mammalian di-
estive tract (Table 2).
Ptc-1 mRNA and protein are expressed in similar
ocations to Shh in the adult human gut. Although
inimal Ptc-1 has been detected in the esophagus, there
s abundant expression in the glands of the stomach.1
able 2. Expression of Shh, Ihh, and Ptc-1 in the Human Adu
Esophagus Stomach
hh protein  
hh mRNA  
hh protein ? ?
hh protein ? ?
tc-1 protein Background 
OTE. There are no published data for expression of Ptc-2 or Gli-1, -2,
, Present; , absent; ?, data not published.RNA was present in the base of the villi and the lamina bropria of the small intestine, with protein also detected
n the tips of villi.1 In the colon, mRNA and protein
ave been detected in the luminal epithelium and subad-
acent lamina propria by Nielson et al1 and also basally in
solated crypt cells by Oniscu et al.64 Further character-
zation of the population of Ptc-1-positive cells in the
amina propria, as well as the basally located cells (sug-
ested to be neuroendocrine in origin64) is required. Smo
rotein is only found at the brush border of the super-
cial colonic epithelium.64 There are no data for Gli1-3
rotein expression in the adult GI tract; however, a
unctional role remains probable, given the developmen-
al data. Analysis of fetal and adult colonic mRNA by
everse-transcription polymerase chain reaction (RT-
CR) confirms expression, if not location, of all essential
h signalling components (Shh, Ptc-1, Smo, Gli1, Gli2,
nd Gli3).67
Functional Aspects of Hh Signalling in the
Adult GI Tract
Shh as a Polarizing Signal for Fundic Gland Dif-
erentiation in the Stomach. Within the stomach, there
re 2 compartments relative to the position of the epithelial
tem cell. In the pit region, cells are migrating toward the
astric lumen, and, in the gland region, they migrate in the
pposite direction. Shh expression is restricted to the glan-
ular portion of both human and murine stomach (utilizing
astric mucins as genetic markers for each compartment). In
umans, Shh expression has been shown by Van den Brink
t al to be greatest at the pit-gland transition and restricted
o parietal cells (as confirmed by double staining with
KATPase).63,68 Ptc-1 is expressed on the epithelial
ells of the gastric gland region and some of the interstitial
ells. Pit cells are Ptc-1 negative, but parietal cells and
pithelial cells at the base of the glands express Ptc-1.68
Shh expression correlates with fundic gland type, as
een where there is loss or gain of fundic gland differen-
iation. In chronic gastritis, in which there is intestinal
etaplasia (as identified by the presence of MUC2), there
s a loss of Shh expression.68 However, Dimmler et al
uggest that this may be related to the process of atrophy
Tract
ll intestine Colon Liver Pancreas
  ? 
  ? 
?   
? ? ? 
  ? 
3 in any of these locations or Dhh anywhere other than the pancreas.lt GI
Sma





























































































November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1703is.63 In the esophagus, Shh is present in parietal cells
HKATPase positive) when they are present in Bar-
ett’s resection specimens. Areas of Meckel’s diverticu-
um containing parietal cells are also positive for Shh
xpression.68
These data show that Shh may play a role as an
ssential polarizing signal for fundic gland differentia-
ion. It has been postulated that an intestinal epithelium
ay be the default state during development. Shh ex-
ression is part of a regulatory network that induces the
haracter of gastric epithelium compared with intestinal
ype. This is then maintained by Shh signalling through-
ut adult life.
Ihh and Regulation of Colonic Enterocyte Differ-
ntiation. Cyclopamine treatment markedly alters the
lender nucleus and cytoplasm of normal terminally dif-
erentiated enterocytes. Without Hh pathway activity
he enterocytes at the luminal end of the crypt have an
nlarged nucleus and large cytoplasm. In addition, they
how significantly altered expression of 3 molecular
arkers of enterocyte differentiation, with redistribution
f villin to the cytoplasm, decreased carbonic anhydrase,
nd increased intestinal trefoil factor.49 In the HT-29
olon carcinoma differentiation model, treatment of cells
ith butyrate induces expression of villin and Cip-1 and
nduces Ihh expression. Blocking Hh signalling with
yclopamine substantially decreases the Cip-1 and villin
nduction with butyrate. In addition, giving recombi-
ant N-terminal Shh (91% homologous to Ihh) leads to
nduction of Cip-1 and villin. These data suggest a role
or Ihh in regulating colonic epithelial differentiation in
ivo and in vitro.
Furthermore, Hh signalling restricts expression of
MP-4 (a Dpp homolog coexpressed with Hh genes
uring development) and engrailed-1 (a Wnt target
ene) to the precursor cell compartment at the base of the
olonic crypt. -Catenin-TCF (a marker of Wnt pathway
ctivity) signalling can be completely abrogated by Ihh
n colon cancer cells.49
Where Wnt pathway activity is constitutively over-
xpressed (adenomatous polyposis coli [APC] gene mu-
ations in familial adenomatous polyposis), Ihh expres-
ion is lost. This phenomenon is observed in familial
denomatous polyposis (FAP) resection specimens that
ontain both normal and dysplastic epithelial cells (cor-
esponding to APC mutations and Wnt overactivity).
ormal Ihh expression is noted in the normal epithelial
ells, but this is lost in dysplastic cells.
Inhibiting -catenin-TCF signalling in colon cancer
ells causes rapid induction of Ihh expression. These data
ogether indicate that Ihh expression is negatively regu-
ated by -catenin-TCF signalling. Furthermore, de- preased Ihh expression in colonic polyps is seen in re-
ponse to the Wnt-activating APC mutation. Because
he loss of differentiation observed in the cyclopamine-
reated colonic epithelial cells mirrors that seen in colo-
ectal carcinogenesis, loss of Ihh may have a role to play
n the development of dysplasia.49
As discussed, all methods currently available to ma-
ipulate Hh pathway activity are nonspecific for Shh or
hh. The reported data are heavily reliant on expression
tudies, and, as previously shown, there remains some
onflict with other published literature (as is further
iscussed below in the specific context of colon cancer). It
s therefore once again difficult to ascribe the effects seen
ere to one Hh homologue or another. Greater specificity
ould now be achieved through the appropriate applica-
ion of RNA interference technology, utilizing specific
equences of double-stranded RNA to knock down the
xpression of complementary genes and determine the
elative contributions of Shh and Ihh in homeostasis of
he adult digestive tract.
Ihh and the Adult Pancreas. In contrast to the
egative influence of Shh on developing pancreatic
rowth, there does appear to be a role for Ihh in the adult
ancreas. Ihh (and to a lesser extent Dhh) is expressed in
slet and -cells in characteristic small, highly localized
ggregates or punctates.37,69,70 Ptc-1 and Smo have been
hown to be expressed in islets, localized to -cells by
oexpression with insulin. The insulin-secreting clonal
ell line INS-1 expresses Ihh, Ptc-1, and Smo. Activation
f the Hh signalling pathway by ectopic misexpression of
hh increased activity of the rat insulin I promoter.37 The
dministration of cyclopamine decreased insulin I pro-
oter activity, decreased insulin secretion, and insulin
ontent of these cells in a concentration-dependent man-
er.37 These data imply that the Hh signalling pathway
lays an important role in the regulation of insulin
roduction in the murine pancreas. The expression data
uggest that Ihh and Dhh are the active Hh homologues
n this process. However, the functional data described
sed Shh to activate Hh signalling, and cyclopamine to
lock pathway activity in a manner not specific for any
h homologue, so there remains a degree of uncertainty.
Hh Signalling and GI Disease
We have seen that Hh signalling is critical to
ormal GI development and that it may have an impor-
ant role to play in homeostatic processes of the adult
tomach, colon, and pancreas. These processes rely on
ime-dependent and tissue-specific signalling at distinct
oncentrations. This is made possible by differential ex-






























































































1704 LEES ET AL GASTROENTEROLOGY Vol. 129, No. 5ranscriptional and negative feedback loops (created by
igand-induced activation of negative regulators, Ptc and
ip1), regulatory interactions with WnT/-catenin sig-
alling, and the pathway’s ability to function as a bist-
ble genetic switch, flipping cell fates at precise, thresh-
ld Shh concentrations.71
However, as a result of this reliance on such tight
ontrol, increases or decreases in pathway activity can
esult in severe defects. It is important to consider how a
evelopmental pathway that normally directs differenti-
tion and proliferation may, with the loss of its normal
trict controls, contribute to cancer formation and main-
enance and chronic intestinal inflammation.
Hedgehog Signalling and Tumorigenesis
The Hh signalling pathway interacts directly
ith cell-cycle components to increase cell proliferation.
he G1-S transition is promoted by cyclins D and E,
oth transcriptional targets of Ci in Drosophila,72 a
nding confirmed in mammalian cells.73 The G2-M
ransition is in part controlled by Ptc, which regulates
he activation of cyclin B (part of the mitosis-promoting-
actor complex).74 Shh also blocks p21(CIP1/WAF1)-induced
rowth arrest.75 Furthermore, there is some evidence that
tc, like deleted in colorectal cancer (DCC), UNC5, and
ET, functions as a dependence receptor.76,77 Depen-
ence receptors are characterized by a cellular state of
ependence on their ligand, such that absence of ligand
nduces apoptosis.78 The presence of ligand (Hh) pre-
ents the induction of apoptosis (Figure 1B). In the
bsence of Hh, caspase-3-mediated cleavage of the intra-
ellular Ptc domain exposes a receptor region that trans-
uces the apoptotic signal via Gli-3 (Figure 1A). It is
oteworthy that many of the Hh pathway activating
tc-1 mutations implicated in central nervous system
CNS), skin, and muscle tumors map to the carboxy-
erminus in the vicinity of the caspase-3 site.79 Such
ritical functions as cell cycle control help to explain the
mportance of tight, multilayered control on the path-
ay. It is perhaps, however, not surprising to learn that
h signalling is implicated in the induction and main-
enance of cancer.80–84 This is, in part, by promoting cell
ycle proliferation and opposing the normal stimuli for
ell cycle arrest.
To date, aberrant Hh signalling has been described in
umors of the skin, brain, lung, and digestive
racts.81,85–89 A subset of Hh-responsive cancers is, in
art, caused by mutations in Hh pathway components.
his phenomenon was first identified in patients with
orlin syndrome, who, along with generalized body
vergrowth, cysts, and skeletal developmental abnormal-
ties, have a predisposition to benign and malignant meoplasia, notably multiple basal cell carcinomas.90,91
atients inherit a mutant Ptc that permits constitutive
athway activation. A mutation in Ptc is also present in
proportion of medulloblastomas and rhabdomyosarco-
as, in which there is evidence that this confers on
umor cells the ability to resist apoptosis.92 This loss of
unction phenotype defines Ptc as a tumor suppressor
ene and is consistent with its role as a dependence
eceptor. Somatic mutations in the Ptc gene are reported
n esophageal squamous cell carcinomas and transitional
ell carcinomas of the bladder.93,94 Other oncogenic mu-
ations include Smo in basal cell carcinoma (in which the
athway becomes independent of Hh-Ptc binding)95 and
uFu in medulloblastoma,96 whereas ectopic expression
f Gli causes glioma.97
It is now known that the Hh pathway is also involved
n the formation and maintenance of some sporadic tu-
ors without implicating pathway activating mutations.
his is seen to be the case for small cell lung cancer,89
rostate cancer,98 pancreatic cancer,88 cholangiocarci-
oma, and other tumors of the digestive tract.86
Pancreatic Cancer
Although Shh and Ptc-1 are not detected in nor-
al adult human pancreata, Shh is aberrantly expressed
n pancreatic adenocarcinoma and its precursor lesions.88
ith the increasing degree of atypia observed in the
uctal epithelium through the precursor lesions
panIN-1 to -3), there is increasing Shh expression. Ihh
s present in normal pancreatic islet cells, and up-regu-
ated in adenocarcinomas, both in islets and in cancer
ells.70 Ptc-1 protein is present in the abnormal epithe-
ium and the surrounding reactive mesenchymal cells of
uman neoplastic pancreata. Ptc-1 mRNA levels are up
o 5000-fold higher in pancreatic tumors than in adja-
ent normal tissue,86 although there is wide variation in
his figure, and a much more conservative up-regulation
f Ptc-1 is suggested by Kayed et al.70 Smo is also
ver-expressed in neoplastic tissue. Thayer et al have
urther explored this association using a Pdx-1-Shh
ouse model that generates misexpression of Shh in the
ancreas (by using the pancreatic-specific Pdx-1 pro-
oter to drive Shh expression).88 These transgenic ani-
als show abnormal pancreatic development, with mor-
hologic changes resembling human ductal PanIN. They
lso develop similar genetic changes to pancreatic ade-
ocarcinomas—overexpression of epithelial Her2/neu,
nd occasional K-Ras mutations.99–101 Unfortunately,
dx1-Shh mice die at 3 weeks of age, so another model
ill be required to assess the impact of Hh signalling on





























































































November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1705Pancreatic adenocarcinoma cell lines from both pri-
ary and metastatic tumors show sustained Hh signal-
ing activity.88 This has been confirmed by demonstrat-
ng significantly elevated luciferase activity on
ransfection of a Gli-luciferase reporter construct into
hese cell lines. Most cell lines express Smo, and of those
alf respond to cyclopamine treatment with increased
poptosis (2.5- to 3.5-fold), decreased cell proliferation
up to 75%–80%), and abolished luciferase activity.88
ayed et al has shown this decreased cell proliferation to
e due to G0/G1 cell cycle accumulation.70 The lack of
esponse in the remaining half suggests that mutations in
ther Hh components, downstream of Smo, contribute to
he abnormal proliferation. It must also be considered
hat mutations in Hh-independent pathways play a role
n these cyclopamine-resistant cell lines.
The ability of cyclopamine to inhibit tumor cell
rowth has been confirmed by Thayer et al in vivo.88
yclopamine-sensitive cells injected into a nude mouse
ere treated with cyclopamine either concurrently from
nitiation or delayed until subcutaneous tumors were
alpable. The latter group showed a 50%–60% decrease
n tumor mass compared with controls, a figure that
ncreased to an 84% reduction in the concurrent group.
he treated tumors were seen as loose epithelial cell
ggregates with a 6-fold increase in apoptotic cells by
UNEL assay. The effective cessation of ligand-depen-
ent Hh signalling does not apparently cause these mice
ny unwanted effects, a finding confirmed in other stud-
es.85,86,88,89
Interestingly, the Hh inhibitor Hip1 may play a role
n pancreatic tumorigenesis. Hip1 expression is lost in
ost pancreatic adenocarcinoma cell lines,88 and Hip-
/ mice, although dying shortly after birth,22 show
ncreased pancreatic Hh signalling during development
Table 1).23 Genetic analysis of a family with a very high
requency of pancreatic adenocarcinoma has mapped the
enetic location responsible to the chromosomal region
q32-34.102 Hip-1 is located immediately adjacent to
his region, suggesting that a mutation in this gene may
ctivate pancreatic Hh signalling and thereby initiate
nd maintain tumor formation.
Other Cancers of the Upper GI Tract
The Hh signalling pathway is active in many
igestive tract cell lines. Shh and Ihh mRNA is present
n virtually all cell lines from esophageal, stomach, bil-
ary tract, pancreatic, and colonic carcinomas. However,
tc-1 and Gli, used as markers of Hh pathway activity,
re coexpressed only in esophageal (4/6), stomach (6/6),
iliary tract (5/9), and pancreatic (5/6) tumors (numbers
n parentheses refer to cell lines). In these cell lines, the tli-luciferase reporter assay shows a high level of activity
nd therefore confirms autonomous pathway activity. Of
he Ptc-1 mRNA-positive cell lines, treatment with
yclopamine resulted in a 75%–95% decrease in growth.
tc-1-negative cell lines show no difference in growth
ith cyclopamine treatment.
The dramatic in vivo responses of pancreatic tumors to
h blockade have been paralleled by experiments de-
cribed by Berman et al, who have studied murine xeno-
rafts created from a human metastatic cholangiocarci-
oma cell line.86 180 mm3 tumors treated with
yclopamine regressed completely in 12 days and re-
ained histologically undetectable in mice that by 3
onths post treatment had shown no ill effects of the
yclopamine treatment. The control animals killed at 22
ays had tumors averaging 800 mm3. In contrast to the
onstitutional activation of Hh signalling caused by mu-
ant Ptc-1 in Gorlin syndrome, these tumors are depen-
ent on Hh-ligand for growth. This has been demon-
trated by the concentration-dependent decrease in
umor growth and luciferase activity with the ligand
lockade (Shh and Ihh) achieved using the 5E1 mono-
lonal antibody (Figure 2).86 Tumor growth was partly
escued with the addition of endogenous Shh.
Colon Cancer
Although the survey of digestive tract tumors by
erman et al failed to establish active Hh signalling
ithin a panel of 11 cell lines, Shh and Ihh mRNA were
etected in all cell lines, and Gli was present in 4 out of
1. Furthermore, Qualtrough et al have shown expres-
ion of mRNA and protein of Shh, Ihh, Ptc-1, Smo, and
li1 in all 5 cell lines they tested.103 Of these, the
denoma-derived cell lines (AA/C1 and RG/C2) have
igher levels of Ihh expression than the adenocarcinoma-
erived lines (CaCo2, HT29, and SW480) but slightly
ower levels of Ptc-1, Smo, and Gli. These observations
ay reflect the evolving role of Hh signalling with
umor phenotypic progression. All these cell lines, how-
ver, show a dose-dependent response to cyclopamine
reatment, with decreased cell yield, increased apoptosis,
nd decrease in autocrine Hh signalling (decreased Gli-
uciferase reporter activity). This effect is partially res-
ued with endogenous Shh-N protein. Similarly, Oniscu
t al demonstrate Shh to have a mitogenic effect on
olonic cell lines that is reversible with cyclopamine.64
urthermore, these authors were able to show increased
hh, Ptc-1, and Smo expression in resected human ade-
ocarcinomas, with intermediate levels in dysplastic tis-
ue and benign adenomas.
Together, these results suggest a functional role for






























































































1706 LEES ET AL GASTROENTEROLOGY Vol. 129, No. 5rowth. However, there is a significant discrepancy with
he observation of Van den Brink et al that loss of Ihh
xpression may be an important step to the establish-
ent of the malignant colonic phenotype, as discussed
bove.49 Although the different Hh homologues share
ery similar signalling properties such as providing a
roliferative stimulus to epithelia, 2 factors help explain
he conflicting data in the healthy and malignant colon.
irst, in certain situations, Shh and Ihh have distinct
iologic functions, as demonstrated in the digit dupli-
ation studies by Pathi et al.4 Second, location of Shh and
hh within distinct compartments of the colon is prob-
bly functionally important. With this in mind, it has
een suggested that Shh provides the proliferative stim-
lus in the colon, whereas Ihh promotes epithelial dif-
erentiation by inhibiting proliferation.104 We suggest
hat a greater understanding of the colonic distribution
f Shh and Ihh and their relative local biologic properties
s needed to help further unify these data.
There is evidence that redundancy and cross talk
ithin the Hh signalling pathway may prevent effective
lockade in some cancers.105,106 Therefore, further clari-
cation of the mechanistic links between Hh signalling
nd carcinogenesis will be critical to the translation of
his research into successful chemotherapeutic strategies.
t is equally important to determine why only certain
ubsets of GI malignancy demonstrate dysregulated Hh
ignalling and to clarify the differences demonstrated
etween the upper and lower digestive tract. Once these
urther data are available, it may then be possible to
dentify patient subpopulations that will derive the
reatest clinical benefit from complete abrogation of the
h signal.
Hedgehog Signalling and Chronic
Inflammation in the GI Tract
There is increasing evidence to implicate a reca-
itulation of embryonic Hh signalling in normal and
athogenic inflammation. This has been shown in re-
ponse to several insults, including acute epithelial in-
ury, skeletal muscle ischemia,107 bone fracture,108 and
hronic pancreatitis.69 In the latter, there is increased
hh, Ptc-1, and Smo with expression identified in the
ells forming tubular complexes and in the islets (with
oss of the punctuate staining pattern seen previously).69
n the lung epithelium, there is extensive activation of
he Hh pathway in response to acute airway injury89 and
n chronic lung fibrosis.109 Much of the work done in the
ung suggests that Shh (like KGF and FGF-10110,111) is
nvolved in repair to epithelial injury, with the primary
im of restoring continuity to areas of denuded epithe- wium, thus minimizing input of pathogenic agents across
his barrier.
Our group has shown Shh-mediated signalling to be a
hysiologic component of peripheral T-lymphocyte re-
ponses109,112,113 (reviewed in Benson et al114). Shh acts
o modulate CD4 T-cell effector function,113 with
ndogenously produced Shh playing a role in sustaining
ormal CD4 T-cell proliferation.112 This response was
nhanced by adding exogenous Shh. We suggest that the
athway’s role in the remodelling of injured pulmonary
pithelium is in part mediated by Hh-ligand communi-
ation of tissue injury to Ptc-1-positive immune cells,
ncluding CD4 T lymphocytes and macrophages.109
The critical question as to whether Hh signalling is
rotective or whether it is pathogenic remains unan-
wered. In some immunopathologic disorders, the Shh
athway functions as a possible repair mechanism, but it
ould also have a damaging effect.114 Intriguingly, the
roinflammatory mediator NF-B appears to up-regulate
hh expression (http://www.mgh.harvard.edu/gensurg/
ensurg_research.htm).
Recent preliminary findings from Nielson et al sug-
est that Shh may be up-regulated in areas of chronic GI
nflammation.1 This was shown by immunohistochemis-
ry and in situ hybridization in Barrett’s esophagus,
astritis, Crohn’s disease, and ulcerative colitis. Al-
hough not quantitative, the authors’ findings show that,
uring chronic inflammation, mRNA expression was
trong throughout the epithelium from base to lumen,
ith loss of the crypt-villous pattern normally identified
n normal intestinal tissues. The authors also report
ncreased Shh protein expression, although this is not
eadily evident in the published photographs. Ptc-1
RNA and protein were expressed in metaplastic and
egenerating epithelial cells and in the crypts but not in
he inflamed colonic surface epithelium. Inflammatory
ells in inflamed mucosa stained for Shh and Ptc-1
rotein and mRNA. The extension of Shh mRNA from
rypt base to include luminal epithelium may represent
ither expansion of the stem cell compartment or delayed
ifferentiation.
As in acute epithelial injury in the lung, Hh may serve
protective function in acute GI epithelial injury. In a
urely hypothetic model, it is suggested that injured
pithelium, via the release of Shh, may communicate
amage to both neighboring epithelial cells via an auto-
rine signal and to CD4 T lymphocytes, macrophages,
nd intestinal subepithelial myofibroblasts in the lamina
ropria that express Ptc-1 and are thus capable of pro-
essing a Shh signal. This process could help repair
amaged epithelium by local signals and communication






























November 2005 HEDGEHOG SIGNALLING PATHWAY IN THE GI TRACT 1707Could Hh signalling play a role in cancers arising in
reas of chronic inflammation? Beachy et al hypothesize
hat these cancers represent the continuous operation of
n up-regulated state of tissue repair associated with
hronic activation of pathways such as Hh and Wnt.115
his is compatible with the probability that increasing
ellular resistance to injury and death creates an epithe-
ium populated by genetically damaged cells. Addition-
lly, the persistence of stem cells or the abnormal distri-
ution of Shh may contribute to the malignant
ransformation. This may have implications for the pre-
ention, diagnosis, and treatment of colitis-associated
ancer, adenocarcinomas arising out of Barrett’s esopha-
us, cholangiocarcinomas in primary sclerosing cholan-
itis, and even hepatomas arising on a background of
irrhosis.
Conclusion
The GI system provides a clear illustration of how
he study of one embryonic signalling pathway can in-
orm such diverse disciplines as molecular biology, tu-
or biology, stem cell research, and immunology. Fur-
her understanding will arise as the complex interactions
etween Hh signalling and the other pathways involved
n GI development (BMP, Notch, and Wnt/-catenin)
re unravelled. In the meantime, the clinical applications
f this laboratory research effort are coming closer to
ealization. This is perhaps best illustrated with pancre-
tic cancer, in which there exists the possibility of not
nly improving diagnosis (by examining pancreatic
uices for increased concentrations of Hh components)
ut also developing new treatments by abrogating the
h signal that drives tumor growth.86,88,106
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